Compare plans using the Plan Finder Tool The Health Connectors Plan Finder Tool lets you compare carrier networks, check whether specific doctors and hospitals are covered, and verify prescription drug formularies before selecting a plan
Mounjaro is FDA-approved to: Control blood sugar levels in adults and children ages 10+ with type 2 diabetes mellitus Zepbound is FDA-approved to: Reduce excess body weight and manage weight long term in adults with obesity or overweight who have at least one weight-related health condition (e.g
By activating GLP-1 receptors in the pancreas, brain, and digestive system, semaglutide triggers several beneficial effects: Increased Insulin Secretion : Stimulates the pancreas to release more insulin when blood sugar levels are high
doi: 10.1111/dom.12932, 9 BoothM
The most well-known GLP-1 medications available in the US in 2026 are Wegovy and Ozempic (both contain semaglutide), and Zepbound and Mounjaro (both contain tirzepatide, a dual GIP/GLP-1 agonist)
Some clinicians attempt dose reduction to the lowest effective level, but this approach should be undertaken only under medical supervision with appropriate monitoring of A1C, weight, and metabolic parameters